Exchange: NASDAQ·Updated 12:00 AM EST

LVTXLAVA Therapeutics NV

$1.74
$0.00
(0.00%)
Pre-Market
Prev Close $1.74
Reported EarningsAug 13
Mkt Cap$45.77M
Vol285,521.00
News
all
press releases
LAVA Therapeutics Stock Drops After Amended Deal With XOMA Royalty
As per the amended deal, LAVA shareholders will receive an initial cash payment of $1.04 per share, down from the range of $1.16 to $1.24 initially agreed upon.
Stocktwits
LAVA Therapeutics Stock Slips 9% Pre-Market – Here’s Why The Company Canceled Its Shareholder Meeting
The firm stated it canceled the meeting to consider and approve certain matters related to its proposed transaction with XOMA Royalty Corporation.
Stocktwits
<
...
1
>

Advertisement|Remove ads.